Novo Nordisk Announces Major Workforce Reduction as Part of Strategic Restructuring
Copenhagen, Denmark – Novo Nordisk, the leading Danish pharmaceutical company known for its weight-loss drug Wegovy, has announced a major workforce reduction, cutting 9,000 jobs, or roughly 11% of its global workforce. The restructuring will impact operations in Denmark and worldwide and is aimed at refocusing efforts on obesity and diabetes treatments amid growing market … Read more